Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View Item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

Thumbnail
View/Open
Accepted version (122.5Kb)
Publication Date
2016-10
ICR Author
van der Graaf, Wilhelmina
Author
Bol, KF
van den Bosch, T
Schreibelt, G
Mensink, HW
Keunen, JEE
Kiliç, E
Japing, WJ
Geul, KW
Westdorp, H
Boudewijns, S
Croockewit, SAJ
van Rossum, MM
de Goede, AL
Naus, NC
van der Graaf, WTA
Gerritsen, WR
de Klein, A
Punt, CJA
Figdor, CG
Cohen, VM
Paridaens, D
de Vries, IJM
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/340
Collections
  • Clinical Studies
Version of record
10.1016/j.ophtha.2016.06.027
Subject
Dendritic Cells
CD8-Positive T-Lymphocytes
Humans
Melanoma
Uveal Neoplasms
Monophenol Monooxygenase
Cancer Vaccines
Disease-Free Survival
Vaccination
Survival Rate
Adult
Aged
Middle Aged
Female
Male
gp100 Melanoma Antigen
Research team
Clinical and Translational Sarcoma
Language
eng
Date accepted
2016-06-06
License start date
2016-10
Citation
Ophthalmology, 2016, 123 (10), pp. 2265 - 2267

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.